Nov 18, 2020 / 09:00PM GMT
Operator
Thank you for standing by, and welcome to the AFT Pharmaceuticals Half Year Results Analyst Briefing. (Operator Instructions)
Representing the company today, we have our Managing Director, Dr. Hartley Atkinson, and Malcolm Tubby, our CFO, from AFT Pharmaceuticals. I would now like to hand the conference over to Hartley Atkinson. Please go ahead.
Hartley Atkinson - AFT Pharmaceuticals Limited - Founder, CEO, MD & Executive Director
Thank you, Ashley. Thank you, everyone, for joining us today. So maybe just to go through the presentation, if that's okay. So obviously, we have the first page, which is the title page, Page 2. We have the various disclaimers, so please just be aware of those. They're pretty standard. And maybe then to move on to Page 3, which is the financial highlights for H1 FY 2021. So basically, to look at some top line numbers, The number of countries which we're selling Maxigesic in continues to grow. We're up 21% to 34 countries. That's an important matrix as over time, clearly, as we sell it in more countries, then that will
Half Year 2021 AFT Pharmaceuticals Ltd Earnings Call Transcript
Mar 28, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers